Innoviva Specialty Therapeutics

Develops therapies for critical care and infectious diseases.

Founded 2022 · 96 employees · United States · Public

Listed:

NASDAQ: INVA

Subsidiaries:

La Jolla Pharmaceutical Company, Entasis Therapeutics